Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype

SIMPLE SUMMARY: Chondrosarcoma (ChS) is the second most frequently diagnosed malignant bone tumor of cartilaginous origin and is generally resistant to standard treatment options. In this paper, we aim to review the current state of the knowledge regarding ChS. We discuss the genetic, epigenetic, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zając, Agnieszka, Król, Sylwia K., Rutkowski, Piotr, Czarnecka, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001927/
https://www.ncbi.nlm.nih.gov/pubmed/33804155
http://dx.doi.org/10.3390/cancers13061317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001927/
https://www.ncbi.nlm.nih.gov/pubmed/33804155
http://dx.doi.org/10.3390/cancers13061317

Ejemplares similares